The PNC Financial Services Group, Inc. filed Amendment No. 3 to Schedule 13G on November 6, 2026, reporting beneficial ownership of shares in the Avantis US Large Cap Value ETF as of September 30, 2026.
Franklin Templeton, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on November 6, 2026, announcing preliminary financial results for its fourth fiscal quarter and fiscal year ended September 30, 2026.
Pulse Biosciences, Inc. filed a Form 8-K on November 6, 2026, disclosing interim six-month results from its PRECISE-BTN clinical study evaluating the nPulse Vybrance Percutaneous Electrode System for symptomatic benign thyroid nodules.
JPMorgan Chase Financial Company LLC filed a Free Writing Prospectus on November 6, 2026, disclosing the terms of its 2-year Callable Contingent Interest Notes linked to the common stock of American Airlines Group Inc., with a Pricing Date of November 12, 2026 and a …
Dana Incorporated announced on November 6, 2026, the commencement of cash tender offers to purchase any and all of its 4.250% Senior Notes due 2030 and 4.500% Senior Notes due 2032, with an expiration date of November 13, 2026.
HomesToLife Ltd filed Amendment No. 4 to its Form F-1 registration statement on November 6, 2026, disclosing a proposed offering of up to 8,000,000 ordinary shares at an assumed price of US$0.90 per share, targeted exclusively at non-U.S. investors.
Western States Regional Joint Board, Workers United, along with affiliated Workers United entities, filed a Form 4 with the SEC on November 6, 2026, disclosing a sale of 92,809 shares of Amalgamated Financial Corp. common stock on November 4, 2026.
BioCardia, Inc. filed a Form 8-K on November 6, 2026, announcing the completion of a clinical consultation process with Japan's Pharmaceuticals and Medical Devices Agency (PMDA) for its CardiAMP Cell Therapy System, with the company advancing toward submission of a marketing approval application.
Community Trust Bancorp, Inc. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting condensed consolidated financial results for the three and nine months ended September 30, 2026.
Burke & Herbert Financial Services Corp. filed its Form 10-Q for the quarterly period ended September 30, 2026, with the SEC on November 6, 2026, reporting consolidated total assets of $11.034 billion and net income of $36.387 million for the third quarter.